{"id":"https://openalex.org/W2339833489","doi":"https://doi.org/10.1089/adt.2016.708","title":"Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small-Molecule Screening","display_name":"Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small-Molecule Screening","alternate_titles":[],"publication_year":2016,"publication_date":"2016-04-01","ids":{"openalex":"https://openalex.org/W2339833489","doi":"https://doi.org/10.1089/adt.2016.708","mag":"2339833489","pmid":"https://pubmed.ncbi.nlm.nih.gov/27078680"},"language":"en","primary_location":{"id":"doi:10.1089/adt.2016.708","doi":"https://doi.org/10.1089/adt.2016.708","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2016.708","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2339833489"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023061192","display_name":"Karin Engen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Karin Engen","raw_affiliation_strings":["Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026446163","display_name":"Ulrika Rosenstr\u00f6m","orcid":"https://orcid.org/0000-0002-0817-8140","observed_orcids":["https://orcid.org/0000-0002-0817-8140"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ulrika Rosenstr\u00f6m","raw_affiliation_strings":["Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022662144","display_name":"Hanna Axelsson","orcid":"https://orcid.org/0000-0003-2365-1749","observed_orcids":["https://orcid.org/0000-0003-2365-1749"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Hanna Axelsson","raw_affiliation_strings":["Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032587431","display_name":"Vivek Konda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Vivek Konda","raw_affiliation_strings":["Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010941426","display_name":"Leif Dahllund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Leif Dahllund","raw_affiliation_strings":["Drug Discovery and Development Platform, Science for Life Laboratory Stockholm, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Development Platform, Science for Life Laboratory Stockholm, Solna, Sweden","institution_ids":["https://openalex.org/I2800139495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012928409","display_name":"Magdalena Otrocka","orcid":"https://orcid.org/0000-0002-2139-8236","observed_orcids":["https://orcid.org/0000-0002-2139-8236"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Magdalena Otrocka","raw_affiliation_strings":["Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012892811","display_name":"Kristmundur Sigmundsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Kristmundur Sigmundsson","raw_affiliation_strings":["Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032538330","display_name":"Alexandros Nikolaou","orcid":"https://orcid.org/0000-0002-8917-0123","observed_orcids":["https://orcid.org/0000-0002-8917-0123"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Alexandros Nikolaou","raw_affiliation_strings":["Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065113357","display_name":"Georges Vauquelin","orcid":"https://orcid.org/0000-0001-8613-1711","observed_orcids":["https://orcid.org/0000-0001-8613-1711"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Georges Vauquelin","raw_affiliation_strings":["Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091135752","display_name":"Mathias Hallberg","orcid":"https://orcid.org/0000-0002-9835-870X","observed_orcids":["https://orcid.org/0000-0002-9835-870X"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mathias Hallberg","raw_affiliation_strings":["Beijer Laboratory, Division of Biological Research on Drug Dependence, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijer Laboratory, Division of Biological Research on Drug Dependence, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087327635","display_name":"Annika Jenmalm Jensen","orcid":"https://orcid.org/0000-0002-6053-8457","observed_orcids":["https://orcid.org/0000-0002-6053-8457"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Annika Jenmalm Jensen","raw_affiliation_strings":["Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073818850","display_name":"Thomas Lundb\u00e4ck","orcid":"https://orcid.org/0000-0002-8145-7808","observed_orcids":["https://orcid.org/0000-0002-8145-7808"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Thomas Lundb\u00e4ck","raw_affiliation_strings":["Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008347976","display_name":"Mats Larhed","orcid":"https://orcid.org/0000-0001-6258-0635","observed_orcids":["https://orcid.org/0000-0001-6258-0635"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Mats Larhed","raw_affiliation_strings":["Science for Life Laboratory Uppsala, Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Science for Life Laboratory Uppsala, Division of Organic Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I2800139495"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5008347976","https://openalex.org/A5073818850"],"corresponding_institution_ids":["https://openalex.org/I123387679","https://openalex.org/I2800139495","https://openalex.org/I28166907"],"apc_list":null,"apc_paid":null,"fwci":0.9167,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.66287198,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"14","issue":"3","first_page":"180","last_page":"193"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.05079999938607216,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.021700000390410423,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-regulated-aminopeptidase","display_name":"IRAP","score":0.9990000128746033},{"id":"https://openalex.org/keywords/angiotensin-iv","display_name":"angiotensin IV","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cognitive-disorders","display_name":"cognitive disorders","score":0.6980000138282776},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.8140000104904175},{"id":"https://openalex.org/keywords/enzyme-activity-assay","display_name":"enzyme activity assay","score":0.7049999833106995},{"id":"https://openalex.org/keywords/non-peptidic-inhibitors","display_name":"non-peptidic inhibitors","score":0.7250000238418579},{"id":"https://openalex.org/keywords/hit-confirmation","display_name":"hit confirmation","score":0.6110000014305115},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.3709999918937683},{"id":"https://openalex.org/keywords/human-orthologs","display_name":"human orthologs","score":0.5249999761581421},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C175656101","wikidata":"https://www.wikidata.org/wiki/Q56646","display_name":"Chinese hamster ovary cell","level":3,"score":0.7093442678451538},{"id":"https://openalex.org/C2780985610","wikidata":"https://www.wikidata.org/wiki/Q419527","display_name":"Aminopeptidase","level":4,"score":0.6514321565628052},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5914577841758728},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.5893844962120056},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4795531928539276},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.4679044187068939},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.441449373960495},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4286264479160309},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21503427624702454},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.14586564898490906},{"id":"https://openalex.org/C2776580952","wikidata":"https://www.wikidata.org/wiki/Q483745","display_name":"Leucine","level":3,"score":0.14152604341506958}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010122","descriptor_name":"Cystinyl Aminopeptidase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/adt.2016.708","doi":"https://doi.org/10.1089/adt.2016.708","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2016.708","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},{"id":"pmid:27078680","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27078680","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Assay and drug development technologies","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1547520663","https://openalex.org/W1551393150","https://openalex.org/W1563650227","https://openalex.org/W1587563234","https://openalex.org/W1966857207","https://openalex.org/W1971543162","https://openalex.org/W1975875968","https://openalex.org/W1979040830","https://openalex.org/W1980243405","https://openalex.org/W1983961909","https://openalex.org/W1987205676","https://openalex.org/W1988994847","https://openalex.org/W1990317939","https://openalex.org/W1991001144","https://openalex.org/W1995184998","https://openalex.org/W1995883062","https://openalex.org/W2005585462","https://openalex.org/W2008949476","https://openalex.org/W2010627562","https://openalex.org/W2013664547","https://openalex.org/W2013682113","https://openalex.org/W2016775336","https://openalex.org/W2018542848","https://openalex.org/W2019097862","https://openalex.org/W2022114028","https://openalex.org/W2027424219","https://openalex.org/W2032310176","https://openalex.org/W2043509228","https://openalex.org/W2045859818","https://openalex.org/W2050588795","https://openalex.org/W2053015924","https://openalex.org/W2055043387","https://openalex.org/W2055699758","https://openalex.org/W2055982079","https://openalex.org/W2070029768","https://openalex.org/W2074682587","https://openalex.org/W2085692714","https://openalex.org/W2086642736","https://openalex.org/W2089966673","https://openalex.org/W2092294261","https://openalex.org/W2096560421","https://openalex.org/W2126898871","https://openalex.org/W2137576308","https://openalex.org/W2142459107","https://openalex.org/W2143549199","https://openalex.org/W2149830384","https://openalex.org/W2155182770","https://openalex.org/W2254157679","https://openalex.org/W2254827003","https://openalex.org/W2317981906","https://openalex.org/W2463036497","https://openalex.org/W2802245552"],"related_works":["https://openalex.org/W3083284709","https://openalex.org/W4394567953","https://openalex.org/W3173259090","https://openalex.org/W2019097862","https://openalex.org/W3013754213","https://openalex.org/W4402629646","https://openalex.org/W1995883062","https://openalex.org/W2022114028","https://openalex.org/W1426939368","https://openalex.org/W3088140707"],"abstract_inverted_index":{"Intracerebroventricular":[0],"injection":[1],"of":[2,7,31,75,82,113,139,172,188],"angiotensin":[3],"IV,":[4],"a":[5,26,55,72,110,164,173,177],"ligand":[6],"insulin-regulated":[8],"aminopeptidase":[9],"(IRAP),":[10],"has":[11],"been":[12],"shown":[13,154],"to":[14,70,94,155],"improve":[15],"cognitive":[16,32],"functions":[17],"in":[18,100,163,169,196],"several":[19],"animal":[20],"models.":[21],"Consequently,":[22],"IRAP":[23,37,141,199],"is":[24],"considered":[25,130],"potential":[27],"target":[28],"for":[29,59,78,136],"treatment":[30],"disorders.":[33],"To":[34],"identify":[35],"nonpeptidic":[36],"inhibitors,":[38],"we":[39],"adapted":[40],"an":[41],"established":[42],"enzymatic":[43],"assay":[44,67,85,167],"based":[45],"on":[46],"membrane":[47],"preparations":[48],"from":[49,92],"Chinese":[50],"hamster":[51],"ovary":[52],"cells":[53],"and":[54,96,122,152,168,176],"synthetic":[56],"peptide-like":[57],"substrate":[58],"high-throughput":[60],"screening":[61],"purposes.":[62],"The":[63,84],"384-well":[64],"microplate-based":[65],"absorbance":[66],"was":[68,87],"used":[69],"screen":[71,98],"diverse":[73],"set":[74],"10,500":[76],"compounds":[77,102,128,147,184],"their":[79],"inhibitory":[80],"capacity":[81],"IRAP.":[83],"performance":[86],"robust":[88],"with":[89],"Z'-values":[90],"ranging":[91],"0.81":[93],"0.91,":[95],"the":[97,137,170,182,189],"resulted":[99],"23":[101],"that":[103],"displayed":[104],"greater":[105],"than":[106],"60%":[107],"inhibition":[108,187],"at":[109],"compound":[111],"concentration":[112],"10":[114],"\u03bcM.":[115],"After":[116,143],"hit":[117],"confirmation":[118],"experiments,":[119],"purity":[120],"analysis,":[121],"promiscuity":[123],"investigations,":[124],"three":[125,146],"structurally":[126],"different":[127],"were":[129,153],"particularly":[131],"interesting":[132],"as":[133],"starting":[134],"points":[135],"development":[138],"small-molecule-based":[140],"inhibitors.":[142,200],"resynthesis,":[144],"all":[145],"confirmed":[148],"low":[149],"\u03bcM":[150],"activity":[151,162],"be":[156],"rapidly":[157],"reversible.":[158],"Additional":[159],"characterization":[160],"included":[161],"fluorescence-based":[165],"orthogonal":[166],"presence":[171],"nonionic":[174],"detergent":[175],"reducing":[178],"agent,":[179],"respectively.":[180],"Importantly,":[181],"characterized":[183],"also":[185],"showed":[186],"human":[190],"ortholog,":[191],"prompting":[192],"our":[193],"further":[194],"interest":[195],"these":[197],"novel":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2339833489","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}
